arrow
T

Takashi Ogawa

pharmaceuticals & medical devices agency
H指数:32
被引数:3,433

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A platform-based regulatory management of recurrent vaccine composition updates using the Post-Approval Change Management Protocol (PACMP)-The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan

基于平台的监管管理方法用于循环更新疫苗成分,采用批准后变更管理协议(PACMP)——日本季节性流感疫苗和COVID-19疫苗的监管框架

2026-08-010
OAAI
Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant

丘脑底核深部脑刺激后携带GBA1变异的帕金森病患者运动和认知结局

2025-11-010
OAAI
VISUAL HALLUCINATIONS IN PARKINSON' S DISEASE WERE ASSOCIATED WITH DECREASING BLOOD FLOW IN THE BILATERAL POSTERIOR CINGULATE CORTEX ON 123I-IMP-SPECT

帕金森病中的视觉幻觉与123I-IMP-SPECT检查中双侧后扣带皮层的血流减少相关。

2025-02-120
OA
Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study

Safinamide作为左旋多巴单药治疗帕金森病患者的辅助治疗: 日本观察性j-silver研究

2024-06-012
PRE
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson's disease in Japan
2023-03-1414
OAAI